MX1 and cancer: Moreover, pro-inflammatory cytokine responses such as TNF-α and IL-17 were significantly reduced in the colon tissues of AOM-DSS-treated Mx1-Cre;Gankyrinf/f mice, which effects were again accompanied by a reduction in expression of cancer stem cell markers and in activation of STAT3 and MAP kinase activation.